INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 882
05/12/2024
Comentaris i suggeriments
Banner-noves-convocatories-02
Cercador de convocatòries
Projectes
23/01/2025
COMISSIO EUROPEA
The European Partnership on Transforming Health and Care Systems (THCS) brings the opportunity to coordinate and optimize research and innovation efforts in Europe and its partner countries supporting the much-needed transformation of health and care systems.
 
01/01/2025
CURE - Citizens United for Research in Epilepsy
The Taking Flight Award seeks to promote the careers of early-career investigators to allow them to develop an independent research focus.
 
01/01/2025
CURE - Citizens United for Research in Epilepsy
CURE Epilepsy’s grant programs seek to accelerate promising research leading to new treatments and cures for people living with epilepsy. CURE Epilepsy prioritizes innovative projects that address our mission, affirming our core belief that the only acceptable final goal is “no seizures, no side effects.”
 
17/01/2025
SOCIETAT CATALANA DE PNEUMOLOGIA
S’estableix un ajut per a la realització de projectes de recerca sobre tema lliure en infermeria i/o fisioteràpia respiratòria.
 
17/01/2025
SOCIETAT CATALANA DE PNEUMOLOGIA
Aquest ajut anirà destinat a investigadors emergents amb edats igual o inferior a 40 anys. S’estableixen un ajut per al desenvolupament de projecte de recerca Pneumològica sobre tema lliure.
 
17/01/2025
SOCIETAT CATALANA DE PNEUMOLOGIA
S’estableix un ajut per al desenvolupament de projectes de recerca pneumològica sobre tema lliure.
 
Altres
17/01/2025
SOCIETAT CATALANA DE PNEUMOLOGIA
Premiar les tesis doctorals d'un tema directament relacionat amb la Pneumologia.
 
Borses de viatge
17/01/2025
European Society for Medical Oncology
Clinical Unit Visits are short-term fellowships that enable young oncologists to spend time at a leading cancer centre
 
22/01/2025
IBSA FOUNDATION FOR SCIENTIFIC RESEARCH
With the aim of promoting and allowing young and talented researchers to do great science, IBSA Foundation for scientific research offers 6 fellowships of € 32.000 in the following research fields:
  • Dermatology
  • Endocrinology
  • Fertility and urology
  • Orthopaedics and rheumatology, pain medicine
  • Healthy aging/Regenerative medicine
    Two grants will be awarded to the scientific area with the highest number of projects received.
    		•
     
    Recursos Humans
    17/01/2025
    SOCIETAT CATALANA DE PNEUMOLOGIA
    S’estableixen dos ajuts per a la realització de projectes de recerca sobre temes lliures en l’àmbit de la pneumologia, per associats titulats en els darrers 2 anys, sense contracte laboral de més de 20 hores setmanals.
     
     
     
    Informació últil
     
     No hi ha novetats
     
     
    Banner-convocatories-tancament-02
    Projectes
    01/01/2025
    CURE - Citizens United for Research in Epilepsy
    The Taking Flight Award seeks to promote the careers of early-career investigators to allow them to develop an independent research focus.
     
    01/01/2025
    CURE - Citizens United for Research in Epilepsy
    CURE Epilepsy’s grant programs seek to accelerate promising research leading to new treatments and cures for people living with epilepsy. CURE Epilepsy prioritizes innovative projects that address our mission, affirming our core belief that the only acceptable final goal is “no seizures, no side effects.”
     
    02/01/2025
    FUNDACIÓN ASOCIACIÓN ESPAÑOLA DE COLOPROCTOLOGÍA
    Aportar tot el suport possible a la recerca independent per part dels seus socis i el moment del seu desenvolupament per a la generació i difusió del coneixement científic en el camp de la Coloproctologia.
    Es convoquen 6 beques de recerca per a la realització de treballs a Espanya.
     
    01/01/2025
    LEO FOUNDATION
    LEO Foundation ‘Open competition grants’ are given to support the best dermatology research projects worldwide.
     
    01/01/2025
    FUNDACIÓN PFIZER
    Pfizer supports the global healthcare community’s independent initiatives to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
     
    20/12/2024
    ALZHEIMER'S DRUG DISCOVERY FOUNDATION
    Funding for projects to develop digital biomarkers for Alzheimer's disease and related dementias.
     
    20/12/2024
    ALZHEIMER'S DRUG DISCOVERY FOUNDATION
    Funding for projects to develop biomarkers for Alzheimer's disease and related dementias accessible from the periphery.
     
    31/12/2024
    FRAXA RESEARCH FOUNDATION
    Grants for clinical research with Fragile X subjects, with preference to projects that have a clear practical application and the results of which will be shared in a timely fashion.
     
    Borses de viatge
    24/12/2024
    DAAD - DEUTSCHER AKADEMISCHER AUSTAUSCH DIENST
    This programme offers you the opportunity to network amongst colleagues and exchange experience in the framework of short-term research stays in Germany.
     
    25/12/2024
    EUROPEAN RESPIRATORY SOCIETY
    1-3 months fellowships for scientists, physicians or qualified allied health professionals, in the early stage of their career, going to another European or overseas country.
     
    24/12/2024
    SEIMC - SOCIEDAD ESPAÑOLA DE ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLÍNICA
    Finançar estades curtes dels seus membres per a intercanvi de coneixements i experiències entre grups de treball dins del país o a l'estranger a l'àmbit de la Microbiologia Clínica i de les Malalties Infeccioses.
     
    31/12/2024
    EUROPEAN HEMATOLOGY ASSOCIATION
    Support to early career researchers by facilitating a visit to a research group in another institute. Both institutes should have complementary expertise, as this visit is intended to promote collaboration between institutes.
     
    Premis
    02/01/2025
    FUNDACIÓN ASOCIACIÓN ESPAÑOLA DE COLOPROCTOLOGÍA
    Es convoquen els Premis Nacionals amb la denominació de “Premis Nacionals de la FAECP” Medtronic 2025 i es premiarà als millors treballs de Coloproctologia publicats per 1a vegada en qualsevol revista nacional o estrangera durant 2024.
     
    24/12/2024
    CHAMPALIMAUD FOUNDATION
    The 2025 António Champalimaud Vision Award recognises groups that contributed to the fight against blindness and visual impairment, primarily in developing regions and/or have developed innovations or new technologies that impact on the quality of life of the blind and visually impaired.
     
    24/12/2024
    FUNDACIÓN GRÜNENTHAL
    Premiar a treballs que versin sobre el dolor, tant en l'àmbit epidemiològic, com experimental, farmacològic o clínic.
     
    24/12/2024
    AEESME - ASOCIACIÓN ESPAÑOLA DE ENFERMERÍA DE SALUD MENTAL
    Estudis relacionats amb la recerca en el camp de la Infermeria de Salut Mental.
     
    24/12/2024
    EFIS - EUROPEAN FEDERATION OF IMMUNOLOGICAL SOCIETIES
    The ACTERIA Prizes are awarded to recognize and reward Europe's young scientists in the fields of immunology and allergology. The Prizes, two each in immunology and allergology, honor outstanding achievements in fundamental research performed in a European institute by researchers with up to 10 years postdoctoral research experience and doctoral theses defended in the last 3 years before the award. The ACTERIA Prizes include individual cash awards plus the potential funding of three-year research projects to be performed in European institutions.
     
    Recursos Humans
    24/12/2024
    DAAD - DEUTSCHER AKADEMISCHER AUSTAUSCH DIENST
    The research grant offers the opportunity to realise a research project in Germany. The programme sup-ports research stays during a doctorate or in the early postdoc phase.
     
    31/12/2024
    AVHF - ALEXANDER VON HUMBOLDT FOUNDATION
    Fellowships for highly-qualified scientists and scholars from abroad, from all disciplines, who completed their doctorates less than four years ago, to spend extended periods of research (6-24 months) in Germany.
     
    31/12/2024
    AVHF - ALEXANDER VON HUMBOLDT FOUNDATION
    Fellowships for highly-qualified scientists and scholars from abroad, from all disciplines, who completed their doctorates less than twelve years ago, to spend extended periods of research (6-18 months; may be divided up into a maximum of three blocks) in Germany.
     
     
     
     
    Articles
     
    Berro-Rivera F*, Cha SW, Aparece JP, Rocimo A, Ong BA, Golbin JM, Alfonso PG, Enkhmaa B, Khan SU, Cainzos-Achirica M, Volgman AS, Navar AM, Shah NP. Sex Differences in Cardiovascular Outcomes and Cholesterol-Lowering Efficacy of PCSK9 Inhibitors: Systematic Review and Meta-Analysis. JACC Adv . 2023; 2(9): 100669 (Acceptat).
     
    Parra-Navarro L*, March-Rodriguez A, Planella-Fontanillas N, Pujol RM. Infantile Hemangiomas of the Vulvar Region: A Therapeutic Challenge. Actas Dermosifiliograf 2024: (en Premsa).
     
    Blanco G*, Morris E, Morris JL, Letson HL, Susheel S, Puiggros A, Espinet B, Chiorazzi N, Dobson GP. Spontaneous Regression Accompanied by Concomitant Immune Alterations in a Patient with Chronic Lymphocytic Leukemia. Ann Case Rep . 2024; 9(1): 1539.
     
    Lafuente E, Terradas R, Civit A, Garcia-Sardelli D, Molina-Huerta C, Lacueva-Pérez L, Estevez PE, Esquinas C*, Tortosa-Moreno A. The Midline Catheter Within the Context of Home Intravenous Antibiotic Treatment. J Infus Nurs . 2024; 47(6): 369-376.
     
    Palomar-Cros A, Deprato A, Papantoniou K, Straif K, Lacy P, Maidstone R, Adan A, Haldar P, Moitra S, Navarro JF, Durrington H, Moitra S, Kogevinas M, Harding BN*. Indoor and outdoor artificial light-at-night (ALAN) and cancer risk: A systematic review and meta-analysis of multiple cancer sites and with a critical appraisal of exposure assessment. Sci Total Environ . 2024; 955: (en Premsa).
     
    Pham U, Chundi A, Stepniewski T, Darbha S, Eiger DS, Gazula S, Gardner J, Hicks C, Selent J, Rajagopal S*. Location-biased β-arrestin conformations direct GPCR signaling. bioRxiv . 2024: .
     
    Morales-Santos A*, Lojo-Lendoiro S, Rovira-Cañellas M, Valdés-Solís P. The legal regulation of artificial intelligence in the European Union: A practical guide for radiologists. Radiología 2024; 66(5): 431-446.
     
    Pena R*, Pascual M. Patient-Reported Outcome Measures (PROMs) in colorectal cancer surgery. Cir Espan 2024: (en Premsa).
     
    Lopez-Lopez V, Kalt F, Zhong JH, Guidetti C, Magistri P, Di Benedetto F, Weinmann A, Mittler J, Lang H, Sharma R, Vithayathil M, Tariq S, Sánchez-Velázquez P, Rompianesi G, Troisi RI, Gómez-Gavara C, Dalmau M, Sanchez-Romero FJ, Llamoza C, Tschuor C, Deniz U, Lurje G, Husen P, Hügli S, Jonas JP, Rössler F, Kron P, Ramser M, Ramirez P, Lehmann K, Robles-Campos R, Eshmuminov D*. Correction to: The role of resection in hepatocellular carcinoma BCLC stage B: A multi-institutional patient-level meta-analysis and systematic review. Langenbecks Arch Surg . 2024; 409(1): 324.
     
    Schröder H*, Juton C, Goran MI, Wärnberg J, Osés M, González Gross M, Gusi N, Aznar S, Marín Cascales E, González Valeiro M.A, Herrera Ramos E, Terrados N, Tur J.A, Segú M, Fitó Colomer M, Ribas-Barbas L, Bautista-Castaño I, Peña-Quintana L, Berruezo P, Benavente Marín J.C, Labayen I, Zapico AG, Sánchez Gómez J, Jiménez Zazo F, Alcaraz PE, Sevilla Sánchez M, Pulgar S, Bouzas C, Serra Majem LL, Gómez SF. Twenty-year trend in the prevalence of increased cardiometabolic risk, measured by abdominal obesity, among Spanish children and adolescents across body mass index categories. BMC med 2024; 22(1): 509.
     
    Lin TY, Motamedi S, Asseyer S, Chien C, Saidha S, Calabresi PA, Fitzgerald KA, Samadzadeh S, Villoslada P, Llufriu S, Green AJ, Preiningerova JL, Petzold A, Leocani L, Garcia-Martin E, Oreja-Guevara C, Outteryck O, Vermersch P, Balcer LJ, Kenney R, Albrecht P, Aktas O, Costello F, Frederiksen J, Uccelli A, Cellerino M, Frohman EM, Frohman TC, Bellmann-Strobl J, Schmitz-Hübsch T, Ruprecht K, Brandt AU, Zimmermann HG*, Paul F. Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores. Neurol Neuroimmunol Neuroinflamm 2024; 11(5): e200269.
     
    López-Campos JL*, Manresa-Presas F, Ruiz-Manzano J, Perpiñá M, Casán P, García-Río F, Barreiro E, Martinez García M.A. Archivos de Bronconeumología: 60 Years and Going on. Arch Bronconeumol 2024: (en Premsa).
     
    Díaz-Carracedo P, Marín C, Díaz-Marsá M, Borges G, de la Torre-Luque A*, Elices M, Toll A, Grande I, Roberto N, Vázquez M, González-Pinto A, Ruiz-Veguilla M, Canal M, Cebriá AI, Palao D, Bobes-Bascarán T, Jimenez-Treviño L, Saiz P, Andreo-Jover J, March K, Palao A, Pérez V, SURVIVE Collaborative Signature. Symptom profile in suicide attempters during the COVID-19 pandemic: Relationships with suicide outcomes. Eur Psychiat 2024; 67(1): e73.
     
    Sendra E, Fernandez-Muñoz A, Zamorano L, Oliver A, Horcajada JP*, Juan C, Gómez-Zorrilla S*. Impact of multidrug resistance on the virulence and fitness of Pseudomonas aeruginosa: a microbiological and clinical perspective. Infection 2024; 52: 1235-1268.
     
    Gasbjerg LS, Rasmussen RS, Dragan A, Lindquist P, Melchiorsen JU, Stepniewski T, Schiellerup S, Tordrup EK, Gadgaard S, Kizilkaya HS, Willems S, Zhong Y, Wang Y, Wright SC, Lauschke VM, Hartmann B, Holst JJ, Selent J, Rosenkilde MM*. Altered desensitization and internalization patterns of rodent versus human glucose-dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge. Br J Pharmacol 2024: (en Premsa).
     
    Gómez-Zorrilla S*, Becerra F, Sendra E, Zamorano L, Grau I, Pintado V, Padilla B, Benito N, Boix L, Fariñas MDC, Penaranda M, Gamallo MR, Martinez JA, Morte-Romea E, Del Pozo JL, Lopez Montesinos I, Duran X, Ponz R, Cortarelo M, Cantón R, Oliver A, Ruiz-Garbajosa P, Horcajada JP*, ITUBRAS-2 Group. Risk factors and clinical impact of multidrug resistance in healthcare-associated bacteraemic urinary tract infections: a post-hoc analysis of a multicentre prospective cohort in Spain. J Hosp Infect 2024; 151: 173-185.
     
    Cubelos-Fernández N, Dávila-Batista V*, Fernández-Villa T, Castaño Vinyals G, Pérez Gómez B, Amiano P, Ardanaz E, Delgado-Sillero I, Llorca J, Fernández Tardón G, Alguacil J, Vanaclocha M, Marcos-Gragera R, Moreno V, Aaragonés N, Dorronsoro A, Guevara M, Reguero S, Pollán M, Kogevinas M, Martín V. Burden of postmenopausal breast cancer attributable to excess body weight: comparative study of body mass index and CUN-BAE in MCC-Spain study. J Epidemiol Community Health 2024: (en Premsa).
     
    Fa-Binefa M, Clará A, Lamas C, Elosua R*. Mediterranean Diet and Risk of Hip Fracture: A Systematic Review and Dose-Response Meta-Analysis. Nutr Rev 2024: (en Premsa).
     
    García-Cosio MD*, Cruzado JM, Farrero M, Peiró MTB, Crespo M, Delgado-Jiménez JF, Diaz-Molina B, Fernandez-Rivera C, Bravo IPG, López-Jiménez V, Melilli E, Mirabet-Pérez S, Pérez-Tamajon ML, Sousa DR, Rodrigo-Calabia E, Hernández-Marrero D*. Management of heart disease in renal transplant recipients: a national Delphi survey-based SET/SEC/SEN consensus document. Rev Esp Cardiol 2024: (en Premsa).
     
    Pérez-Vega KA, Lassale C, Zomeño MD, Castañer O, Salas Salvadó J, Basterra-Gortari FJ, Corella D, Estruch R, Ros E, Tinahones FJ, Blanchart G, Malcampo M, Muñoz D, Schröder H, Fitó Colomer M, Hernáez A*. Breakfast energy intake and dietary quality and trajectories of cardiometabolic risk factors in older adults. J Nutr Health Aging 2024; 28: (en Premsa).
     
    Ruiz-Limón P, Muralidharan J, Gómez-Pérez AM, Murri M, Vioque J, Corella D, Fitó Colomer M, Vidal Alaball J, Salas Salvadó J, Torres-Collado L, Coltell O, Atzeni A, Castañer O, Bulló M, Bernal-López MR, Moreno-Indias I*, Tinahones FJ. Physical activity shifts gut microbiota structure in aged subjects with overweight/obesity and metabolic syndrome. Biol Sport 2024; 41: 47-60.
     
    Gonzáles JA, Barrera M, Kossatz de Mello E, Veza E, de la Torre R, Busquets A*, Robledo P*, Pizarro N*. Microbiota and social behavior alterations in a mouse model of down syndrome: Modulation by a synbiotic treatment. Prog Neuro-Psychopharmacol Biol Psychiatr 2024; 136: (en Premsa).
     
    Tur-Martínez J*, Rodríguez-Santiago J, Osorio-Aguilar J, Miró M, Yarnoz C, Jofra M, Ferret G, Salvador-Roses H, Fernández-Ananín S, Clavell A, Luna A, Aldeano A, Olona C, Hermoso J, Güell-Farré M, Dal Cero M, Gimeno M, Pallarès N, Pera M. Prognostic Relevance of Preoperative Immune, Inflammatory, and Nutritional Biomarkers in Patients Undergoing Gastrectomy for Resectable Gastric Adenocarcinoma: An Observational Multicentre Study. Cancers 2024; 16(12): 2188.
     
    Luque S, Hope W, Kotsaki A, Das S, Giamarellos-Bourboulis EJ, Kontopoulouk T, Akinosoglou K, O'hare M, Attwood MLG, Bowker KE, Noel AR, Lovering AM, Bayliss MAJ, Evans RN, MacGowan AP*. Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA. J Antimicrob Chemother 2024: (en Premsa).
     
    de Medeiros-Oliveira LCL, Pedreira-Robles G, Pérez Sáez MJ, Crespo M, Bach-Pascual A, Rubio-Paez S, Curado-Soto T, Rovira-Algara A, Melilli E, Jerez-Roig J, Oriol-Vila E, Quintana-Reyes C, Diaz-Jurado M, Martins RR, Moreira FSM, Oliveira AG*. Cross-cultural validation of the Spanish version of the Kidney AlloTransplant Immunosuppressive Therapy Adherence Questionnaire (KATITA-25). Sci Rep 2024; 14(1): 24287.
     
    Mesonero F*, Zabana Y, Fernández-Clotet A, Solá A, Caballol B, Leo-Carnerero E, García MJ, Bertoletti F, Bastida G, Suris G, Casis B, Ferreiro-Iglesias R, Calafat M, Jiménez I, Miranda-Bautista J, Lamuela LJ, Fajardo I, Torrealba L, Nájera R, Sáiz-Chumillas RM, González-Partida I, Vicuña M, García-Morales N, Gutiérrez A, López-García A, Benitez JM, Rubín C, Tejido C, Brunet E, Hernandez-Camba A, Suárez C, Rodríguez-Lago I, Piqueras M, Castaño A, Ramos L, Sobrino A, Rodríguez-Grau MC, Elosua A, Montoro M, Baltar R, Huguet JM, Hermida B, Caballero-Mateos A, Sánchez-Guillén L, Bouhmidi A, Pajares R, Baston-rey I, López A, Albillos A, Barreiro de Acosta M, GETECCU Young Members Group. Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU. Digest Liver Dis 2024; S1590-8658(24): 01023-5 (en Premsa).
     
    Sharma M*, Beaudart C, Clark P, Fujiwara S, Adachi JD, Papaioannou A, Messina OD, Morin SN, Kohlmeier L, Nogués X, Leckie C, Harvey NC, Kanis JA, Reginster JY, Hiligsmann M, Silverman SL. Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project. Osteoporosis Int 2024: (en Premsa).
     
    Rompianesi G*, Han HS, Fusai G, López-Ben S, Maestri M, Ercolani G, Di Martino M, Diaz-Nieto R, Ielpo B, Pérez-Alonso AJ, Morare N, Casellas M, Gallotti A, de la Hoz-Rodriguez A, Burdío F, Ravaioli F, Venetucci P, Lo Bianco E, Ceriello A, Montalti R, Troisi RI. Pre-operative evaluation of spontaneous portosystemic shunts as a predictor of post-hepatectomy liver failure in patients undergoing liver resection for hepatocellular carcinoma. Eur J Surg Oncol 2024: (en Premsa).
     
    La Chica Lhöest M.T, Martinez A, Claudi L, Garcia E, Benitez Amaro A, Polishchuk A, Piñero J, Viladés-Medel D, Guerra JM, Sanz F, Rotllan N, Escolà-Gil JC, Llorente-cortés V*. Mechanisms modulating foam cell formation in the arterial intima: exploring new therapeutic opportunities in atherosclerosis. Front Cardiovasc Med . 2024; 11: (Acceptat).
     
    Mateu-Arrom L*, Giménez-Arnau AM, Expósito-Serrano V, Bonfill-Ortí M, Serra-Baldrich E, Yelamos O, Spertino J. Cyclosporine for the treatment of chronic spontaneous urticaria refractory to antihistamines and omalizumab: a case series. Int J Dermatol 2024: (en Premsa).
     
    Lakhwani S*, Mateos MV, Martínez-López J, Paiva B, Rosiñol-Dachs L, Martínez R, Oriol A, Bargay J, González-Montes Y, Gironella M, Encinas C, Martín J, Jarque I, Granell M, Abella E, García-Mateo A, Hernández-Rivas JA, Ramila E, Krsnik I, Casado-Montero LF, de Arriba F, Palomera L, Sampol A, Moraleda JM, Casanova M, Delgado P, Lafuente A, Amutio E, López-Martínez A, Altés A, Ruíz MÁ, Alegre A, López-Anglada L, De La Cruz J, Alonso-Fernández R, Bladé-Creixenti J, Lahuerta JJ, San-Miguel J, Hernández MT. Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease. Ann Hematol 2024: (en Premsa).
     
    Navarro-Pérez MP, González-Quintanilla V, Muñoz-Vendrell A, Madrigal E, Alpuente A, Latorre G, Molina F, Monzón MJ, Medrano V, García-Azorín D, González-Oria C, Gago-Veiga AB, Velasco F, Beltrán I, Morollón N, Viguera-Romero J, Casas-Limón J, Rodriguez-Vico J, Cuadrado E, Irimia P*, Iglesias F, Guerrero-Peral ÁL, Belvís R, Pozo-Rosich P, Pascual J, Santos-Lasaosa S. Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study. Front Neurol 2024; 15: 1417831 (Acceptat).
     
    Calpe-Damians N*, Wennberg-Capellades L, Ventura-Rosado A, Gonzalez-Engroba R, Enríquez-Pérez N, Vicario-Martos C, Roldos-Gales A, Guri T, Rafart-Aguado S, Ramírez-Ramon A, Llauradó-Serra M. Effectiveness and safety of a simple catheter securement device aimed at preventing catheter-associated urinary tract infection in intensive care unit patients: A randomized controlled trial. NURS CRIT CARE 2024; 29: 1788-1798.
     
    Bootsma E*, Voorspoels W, Proost S, Jansen L, Mortier P, Van Den Houte K, Kessler RC, Kiekens G, Tack J, Alonso J, Bruffaerts R, Raes J, Falony G, Vieira-Silva S, Van Oudenhove L, Cuijpers P, Auerbach RP, Gut-Brain Interactions ? WHO ? World Mental Health International College Student Initiative Working Group. Beyond the Norm: Epidemiology of Irritable Bowel Syndrome and Mental Health Among Sexual and Gender-Diverse Young Adults in a Large Representative Cohort. Gastroenterology 2024; 167: 1213-1216.
     
    Cremona S, Llerena GC, de Hollanda A, Robles CJ, Pagano G, Ibarzabal A, Hernández-Évole H, Fundora-Suárez Y*, Crespo G*. Obesity Is Increasing in Liver Transplant Recipients and Exacerbates Cardiovascular Risk: A Single-Centre European Study. Obes Surg 2024: (en Premsa).
     
    Marcos-Delgado A*, Martín Sánchez V, Molina-Barceló A, Alonso-Molero J, Pérez Gómez B, Pollán M, Aaragonés N, Ederra-Sanza M, Fernández Tardón G, Binefa G, Moreno V, Barrios-Rodríguez R, Amiano P, Huerta JM, Teso EP, Alguacil J, Castaño Vinyals G, Kogevinas M, Molina de la Torre AJ. Health-Related Quality of Life in Long-Term Colorectal Cancer Survivors. Healthcare (Basel) . 2024; 12(19): 1917.
     
    Nieto-Pascual L, Lopez-Yarto M, Agüero-Mariño M, Martínez-García S, López-González G, Navarrete-Domínguez J, García-Salmones González C, Lafuente-González P, Sastre-Cuadri ME, Peñaloza-Bustamante J, Doménech A, Augé E, Andeyro-García M. A multi-center study on the use of lidocaine thermogel for pain control in outpatient operative hysteroscopy. Eur J Obstet Gynecol Reprod Biol 2024; 303: 230-235.
     
    Srinivasan S, Kryza T, Bock N, Tse BWC, Sokolowski KA, Janaththani P, Fernando A, Moya L, Stephens C, Dong Y, Röhl J, Alinezhad S, Vela I, Perry-Keene JL, Buzacott K, Nica R, Gago-Domínguez M, Schleutker J, Maier C, Muir K, Tangen CM, Gronberg H, Pashayan N, Albanes D, Wolk A, Stanford JL, Berndt SI, Mucci LA, Koutros S, Cussenot O, Sorensen KD, Grindedal EM, Travis RC, Haiman CA, MacInnis RJ, Vega A, Wiklund F, Neal DE, Kogevinas M, Penney KL, Nordestgaard BG, Brenner H, John EM, Gamulin M, Claessens F, Melander O, Dahlin A, Stattin P, Hallmans G, Häggström C, Johansson R, Thysell E, Rönn AC, Li W, Brown N, Dimeski G, Shepherd B, Dadaev T, Brook MN, Spurdle AB, Stenman UH, Koistinen H, Kote-Jarai Z, Klein RJ, Lilja H, Ecker RC, Eeles R, Clements J, Batra J*, IMPACT Study; PROFILE Study Steering Committee; Practical Consortium; Australian Prostate Cancer BioResource. A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer. Nat Commun 2024; 15(1): 9587.
     
    Márquez-Rodas I*, Alvárez A, Arance A, Valduvieco I, Berciano-Guerrero MA, Delgado R, Soria A, López-Campos F, Sánchez P, Romero JL, Martín-Liberal J, Lucas A, Diaz-Beveridge R, Conde-Moreno AJ, Álamo De La Gala MDC, García-Castaño A, Prada PJ, González-Cao M, Puertas E, Vidal J, Foro P, Aguado-De La Rosa C, Corona JA, Cerezuela-fuentes P, López P, Luna P, Aymar N, Puértolas T, Sanagustín P, Berrocal A. Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study). Neuro Oncol 2024; 26: 2074-2083.
     
    Truchot A, Raynaud M, Helanterä I, Aubert O, Kamar N, Divard G, Astor B, Legendre C, Hertig A, Buchler M, Crespo M, Akalin E, Soler-Pujol G, Ribeiro MC, Matas AJ, Ulloa C, Jordan SC, Huang E, Juric I, Basic-Jukic N, Coemans M, Naesens M, Friedewald JJ, Tedesco-Silva Jr H, Lefaucheur C, Segev DL, Collins GS, Loupy A*. Competing and Noncompeting Risk Models for Predicting Kidney Allograft Failure. J Am Soc Nephrol 2024: (en Premsa).
     
    Sousa-Pinto B*, Ramanauskaite A, Neisinger S, Witte-Händel E, Giménez-Arnau AM, Guillet C, Parisi CAS, Katelaris CH, Fomina D, Larenas-Linnemann D, García E, Kocatürk E, Siebenhaar F, Lima H, Kaidashev I, Nasr I, Ogueta-Canales I, Cherrez-Ojeda I, Hébert J, Bousquet J, Bernstein JA, Peter J, Sánchez J, Larco-Sousa JI, Kulthanan K, Weller K, Godse K, Rutkowski K, Lapina L, Bouillet L, Han L, Ensina LF, Gonçalo M, Magerl M, Van Doorn M, Metz M, Khoshkhui M, Hide M, Türk M, Kurjane N, Conlon N, Salameh P, Kolkhir P, Asero R, Stepanenko R, Altrichter S, Gil-Mata S, Thomsen SF, Zuberbier T, Tsaryk V, Ye YM, Brzoza Z, Zhao Z, Maurer M. Validity, reliability and responsiveness of digital visual analogue scales for chronic spontaneous urticaria monitoring: A CRUSE® mobile health study. Allergy 2024: (en Premsa).
     
    Verlingue L, Italiano A, Prenen H, Guerra-Alia EM, Tosi D, Perets R, Lugowska I, Moiseyenko V, Gumus M, Arslan C, Lindsay CR, Deva S, Taus A, Oaknin A, Rottey S, Cicin I, Goksu SS, Smolin A, Roselló-Keränen S, Habigt C, Marbach D, Boetsch C, Dejardin D, Sleiman N, Evers S, Richard M, Ardeshir C, Charo J, Kraxner A, Teichgräber V, Keshelava N, Dziadziuszko R*. Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma. EBioMedicine 2024; 109: (en Premsa).
     
    Planella-Fontanillas N, Bosch-Amate X, Jiménez-Antón A, Moreno-Vílchez C, Guerrero MG, Del Mar Blanes Martínez M, Ballester-Martínez A, Bassas-Freixas P, Castaño-Fernández JL, Estébanez-Corrales A, Suarez Fernández R, Santos-Alarcón S, Bauza-Aonso A, Torrent M, Ballano-Ruiz A, Collantes-Rodríguez C, España A, Fonseca-Capdevila E, Gil I, Hernández-Fernández CP, Melgosa-Ramos FJ, Spertino J, Zaragoza-Ninet V, Armillas L, Bielsa I, Carrera C, Rafat ME, Fulgencio-Barbarin J, Fernández-Vela J, Lova-Navarro M, Martín-Callizo C, Martín-Sala S, Ojeda R, Parera E, Puigdollers AS, Pujol RM, Podlipnik S, Mascaró JM*, Curto-Barredo L. Real-World Evaluation of the Effectiveness and Safety of Dupilumab in Bullous Pemphigoid: An Ambispective Multicenter Case Series. Br J Dermatol 2024: (en Premsa).
     
    Ballesteros-Ruiz C, Campos-Juanatey F*, Povo-Martín I, Mitjana-Biosca S, Gorría-Cardesa O, Aguilar-Guevara JF, García-Formoso N, Fernández-Pascual E, Martínez-Salamanca JI, Martínez-Pérez S, Alonso-Dorrego JM, Ríos-González E, San Cayetano-Talegon S, Araujo-Suarez AM, Moran-Pascual E, Bonillo-García MA, Medina-Polo J, Viver-Clotet L, Vicens-Morton AJ, Arce-Gil J, Sos-Cambras L, Ibáñez-Vázquez L, Hermida-Gutiérrez J, Moncada-Castro EM, Ponce de León-Roca J, Torres-León L, Martínez-Piñeiro-Lorenzo L. Efficacy and safety of Optilume® paclitaxel-coated urethral dilatation balloon in real-life: experience in a Spanish multicenter study. Actas Urol Esp 2024: (en Premsa).
     
     
    Institut Hospital del Mar d'Investigacions Mèdiques
    Tel: 93 316 04 00
    Doctor Aiguader, 88
    08003 Barcelona
    Seguiu-nos a:
    Twitter
    Youtube
    En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
    Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).